CAMBRIDGE, Mass., May 12 /PRNewswire-FirstCall/ -- Vertex Pharmaceuticals Incorporated will webcast its corporate presentation at the Bank of America Health Care Conference. The presentation and discussion will be delivered by Ian Smith, Vertex’s Executive Vice President and Chief Financial Officer, and John Alam, M.D., Vertex’s Executive Vice President, Medicines Development and Chief Medical Officer, on Wednesday, May 17, 2006 at 10:40 a.m. PDT (1:40 p.m. EDT).
The presentation and discussion will be webcast live and may be accessed by visiting the Vertex website at http://www.vrtx.com. A replay of the webcast will also be available on the Company’s website until June 1, 2006. To access the webcast, go to Vertex’s website and select ‘Bank of America Health Care Conference 2006.’ To ensure a timely connection to the webcast, it is recommended that users register at least 15 minutes prior to the scheduled webcast.
About Vertex
Vertex Pharmaceuticals Incorporated is a global biotechnology company committed to the discovery and development of breakthrough small molecule drugs for serious diseases. The Company’s strategy is to commercialize its products both independently and in collaboration with major pharmaceutical companies. Vertex’s product pipeline is principally focused on viral diseases, inflammation, autoimmune diseases and cancer. Vertex co-promotes the HIV protease inhibitor, Lexiva, with GlaxoSmithKline.
Lexiva is a registered trademark of the GlaxoSmithKline group of companies.
Vertex’s press releases are available at http://www.vrtx.com. Vertex Contact: Lora Pike, Manager, Investor Relations, (617) 444-6755
Vertex Pharmaceuticals Incorporated
CONTACT: Lora Pike, Manager, Investor Relations of Vertex, +1-617-444-6755
Web site: http://www.vrtx.com//
Company News On-Call: http://www.prnewswire.com/comp/938395.html /
